Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design

Eric P. Schmidt, Daniel B Drachman, Charles M Wiener, Lora Clawson, Richard Kimball, Noah Lechtzin

Research output: Contribution to journalArticle

Abstract

The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure impacts patients, clinicians, and clinical investigators. This study compared the abilities of various pulmonary function tests to predict tracheostomy-free survival. We evaluated 95 ALS patients by determining upright and supine forced vital capacity (FVC), maximal inspiratory (MIP) and expiratory (MEP) pressures, arterial partial pressure of carbon dioxide (PaCO2), and transdiaphragmatic sniff pressures (Pdi-sniff). Tracheostomy-free survival time was measured from the date of spirometry. Supine FVC, upright FVC, MIP, MEP, and Pdi-sniff were significantly associated with tracheostomy-free survival after controlling for non-pulmonary factors, whereas PaCO2 was not. A normal supine FVC, MIP, or MEP was highly predictive for one-year survival. These tests are well suited to predict survival for trial enrollment and patient counseling. Supine FVC's simplicity of use and availability to ALS investigators makes it a particularly attractive predictor of one-year survival in ALS.

Original languageEnglish (US)
Pages (from-to)127-132
Number of pages6
JournalMuscle and Nerve
Volume33
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Amyotrophic Lateral Sclerosis
Vital Capacity
Clinical Trials
Lung
Survival
Tracheostomy
Research Personnel
Aptitude
Partial Pressure
Spirometry
Respiratory Function Tests
Carbon Dioxide
Respiratory Insufficiency
Counseling
Arterial Pressure
Pressure

Keywords

  • Amyotrophic lateral sclerosis
  • Prognosis
  • Pulmonary function
  • Spirometry
  • Therapeutic trial design

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Pulmonary predictors of survival in amyotrophic lateral sclerosis : Use in clinical trial design. / Schmidt, Eric P.; Drachman, Daniel B; Wiener, Charles M; Clawson, Lora; Kimball, Richard; Lechtzin, Noah.

In: Muscle and Nerve, Vol. 33, No. 1, 01.2006, p. 127-132.

Research output: Contribution to journalArticle

@article{6307df7c932b4be59b6097cb33b40179,
title = "Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design",
abstract = "The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure impacts patients, clinicians, and clinical investigators. This study compared the abilities of various pulmonary function tests to predict tracheostomy-free survival. We evaluated 95 ALS patients by determining upright and supine forced vital capacity (FVC), maximal inspiratory (MIP) and expiratory (MEP) pressures, arterial partial pressure of carbon dioxide (PaCO2), and transdiaphragmatic sniff pressures (Pdi-sniff). Tracheostomy-free survival time was measured from the date of spirometry. Supine FVC, upright FVC, MIP, MEP, and Pdi-sniff were significantly associated with tracheostomy-free survival after controlling for non-pulmonary factors, whereas PaCO2 was not. A normal supine FVC, MIP, or MEP was highly predictive for one-year survival. These tests are well suited to predict survival for trial enrollment and patient counseling. Supine FVC's simplicity of use and availability to ALS investigators makes it a particularly attractive predictor of one-year survival in ALS.",
keywords = "Amyotrophic lateral sclerosis, Prognosis, Pulmonary function, Spirometry, Therapeutic trial design",
author = "Schmidt, {Eric P.} and Drachman, {Daniel B} and Wiener, {Charles M} and Lora Clawson and Richard Kimball and Noah Lechtzin",
year = "2006",
month = "1",
doi = "10.1002/mus.20450",
language = "English (US)",
volume = "33",
pages = "127--132",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Pulmonary predictors of survival in amyotrophic lateral sclerosis

T2 - Use in clinical trial design

AU - Schmidt, Eric P.

AU - Drachman, Daniel B

AU - Wiener, Charles M

AU - Clawson, Lora

AU - Kimball, Richard

AU - Lechtzin, Noah

PY - 2006/1

Y1 - 2006/1

N2 - The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure impacts patients, clinicians, and clinical investigators. This study compared the abilities of various pulmonary function tests to predict tracheostomy-free survival. We evaluated 95 ALS patients by determining upright and supine forced vital capacity (FVC), maximal inspiratory (MIP) and expiratory (MEP) pressures, arterial partial pressure of carbon dioxide (PaCO2), and transdiaphragmatic sniff pressures (Pdi-sniff). Tracheostomy-free survival time was measured from the date of spirometry. Supine FVC, upright FVC, MIP, MEP, and Pdi-sniff were significantly associated with tracheostomy-free survival after controlling for non-pulmonary factors, whereas PaCO2 was not. A normal supine FVC, MIP, or MEP was highly predictive for one-year survival. These tests are well suited to predict survival for trial enrollment and patient counseling. Supine FVC's simplicity of use and availability to ALS investigators makes it a particularly attractive predictor of one-year survival in ALS.

AB - The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure impacts patients, clinicians, and clinical investigators. This study compared the abilities of various pulmonary function tests to predict tracheostomy-free survival. We evaluated 95 ALS patients by determining upright and supine forced vital capacity (FVC), maximal inspiratory (MIP) and expiratory (MEP) pressures, arterial partial pressure of carbon dioxide (PaCO2), and transdiaphragmatic sniff pressures (Pdi-sniff). Tracheostomy-free survival time was measured from the date of spirometry. Supine FVC, upright FVC, MIP, MEP, and Pdi-sniff were significantly associated with tracheostomy-free survival after controlling for non-pulmonary factors, whereas PaCO2 was not. A normal supine FVC, MIP, or MEP was highly predictive for one-year survival. These tests are well suited to predict survival for trial enrollment and patient counseling. Supine FVC's simplicity of use and availability to ALS investigators makes it a particularly attractive predictor of one-year survival in ALS.

KW - Amyotrophic lateral sclerosis

KW - Prognosis

KW - Pulmonary function

KW - Spirometry

KW - Therapeutic trial design

UR - http://www.scopus.com/inward/record.url?scp=30344479450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344479450&partnerID=8YFLogxK

U2 - 10.1002/mus.20450

DO - 10.1002/mus.20450

M3 - Article

C2 - 16258948

AN - SCOPUS:30344479450

VL - 33

SP - 127

EP - 132

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 1

ER -